MARR SPA (MARR.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:MARR • IT0003428445

9.36 EUR
-0.04 (-0.43%)
Last: Feb 12, 2026, 11:59 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MARR. MARR was compared to 26 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and the financial health of MARR get a neutral evaluation. Nothing too spectacular is happening here. MARR is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • MARR had positive earnings in the past year.
  • In the past year MARR had a positive cash flow from operations.
  • Of the past 5 years MARR 4 years were profitable.
  • MARR had a positive operating cash flow in 4 of the past 5 years.
MARR.MI Yearly Net Income VS EBIT VS OCF VS FCFMARR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • The Return On Assets of MARR (3.98%) is comparable to the rest of the industry.
  • With a decent Return On Equity value of 17.04%, MARR is doing good in the industry, outperforming 73.08% of the companies in the same industry.
  • The Return On Invested Capital of MARR (9.46%) is better than 65.38% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MARR is below the industry average of 9.69%.
  • The 3 year average ROIC (6.59%) for MARR is below the current ROIC(9.46%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.98%
ROE 17.04%
ROIC 9.46%
ROA(3y)3.25%
ROA(5y)2.51%
ROE(3y)11.13%
ROE(5y)8.54%
ROIC(3y)6.59%
ROIC(5y)5.15%
MARR.MI Yearly ROA, ROE, ROICMARR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

  • MARR has a Profit Margin (1.76%) which is in line with its industry peers.
  • MARR's Profit Margin has declined in the last couple of years.
  • The Operating Margin of MARR (3.09%) is worse than 61.54% of its industry peers.
  • In the last couple of years the Operating Margin of MARR has declined.
  • With a Gross Margin value of 7.74%, MARR is not doing good in the industry: 88.46% of the companies in the same industry are doing better.
  • MARR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.09%
PM (TTM) 1.76%
GM 7.74%
OM growth 3Y-4.69%
OM growth 5Y-10.77%
PM growth 3Y-5.22%
PM growth 5Y-12.22%
GM growth 3Y2.34%
GM growth 5Y1.72%
MARR.MI Yearly Profit, Operating, Gross MarginsMARR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MARR is still creating some value.
  • Compared to 1 year ago, MARR has less shares outstanding
  • Compared to 5 years ago, MARR has less shares outstanding
  • The debt/assets ratio for MARR has remained at the same level compared to a year ago.
MARR.MI Yearly Shares OutstandingMARR.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MARR.MI Yearly Total Debt VS Total AssetsMARR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 3.37 indicates that MARR is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.37, MARR is in the better half of the industry, outperforming 73.08% of the companies in the same industry.
  • MARR has a debt to FCF ratio of 27.61. This is a negative value and a sign of low solvency as MARR would need 27.61 years to pay back of all of its debts.
  • MARR has a worse Debt to FCF ratio (27.61) than 80.77% of its industry peers.
  • A Debt/Equity ratio of 1.14 is on the high side and indicates that MARR has dependencies on debt financing.
  • MARR has a worse Debt to Equity ratio (1.14) than 65.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 27.61
Altman-Z 3.37
ROIC/WACC1.51
WACC6.27%
MARR.MI Yearly LT Debt VS Equity VS FCFMARR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • MARR has a Current Ratio of 1.44. This is a normal value and indicates that MARR is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of MARR (1.44) is better than 88.46% of its industry peers.
  • MARR has a Quick Ratio of 1.02. This is a normal value and indicates that MARR is financially healthy and should not expect problems in meeting its short term obligations.
  • MARR has a Quick ratio of 1.02. This is amongst the best in the industry. MARR outperforms 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.02
MARR.MI Yearly Current Assets VS Current LiabilitesMARR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

  • The earnings per share for MARR have decreased strongly by -21.35% in the last year.
  • Measured over the past years, MARR shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.05% on average per year.
  • Looking at the last year, MARR shows a small growth in Revenue. The Revenue has grown by 0.56% in the last year.
  • The Revenue has been growing slightly by 4.24% on average over the past years.
EPS 1Y (TTM)-21.35%
EPS 3Y7.67%
EPS 5Y-8.05%
EPS Q2Q%-27.17%
Revenue 1Y (TTM)0.56%
Revenue growth 3Y12.68%
Revenue growth 5Y4.24%
Sales Q2Q%0.97%

3.2 Future

  • MARR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.60% yearly.
  • Based on estimates for the next years, MARR will show a small growth in Revenue. The Revenue will grow by 3.62% on average per year.
EPS Next Y-10.47%
EPS Next 2Y4.5%
EPS Next 3Y7.6%
EPS Next 5YN/A
Revenue Next Year2.63%
Revenue Next 2Y2.85%
Revenue Next 3Y3.18%
Revenue Next 5Y3.62%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MARR.MI Yearly Revenue VS EstimatesMARR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
MARR.MI Yearly EPS VS EstimatesMARR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.28 indicates a reasonable valuation of MARR.
  • 84.62% of the companies in the same industry are more expensive than MARR, based on the Price/Earnings ratio.
  • MARR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.18.
  • Based on the Price/Forward Earnings ratio of 13.13, the valuation of MARR can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MARR indicates a somewhat cheap valuation: MARR is cheaper than 61.54% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of MARR to the average of the S&P500 Index (28.01), we can say MARR is valued rather cheaply.
Industry RankSector Rank
PE 11.28
Fwd PE 13.13
MARR.MI Price Earnings VS Forward Price EarningsMARR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MARR is on the same level as its industry peers.
  • MARR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 33.28
EV/EBITDA 7.87
MARR.MI Per share dataMARR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.5%
EPS Next 3Y7.6%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 6.49%, MARR is a good candidate for dividend investing.
  • MARR's Dividend Yield is rather good when compared to the industry average which is at 2.49. MARR pays more dividend than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, MARR pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.49%

5.2 History

  • The dividend of MARR decreases each year by -5.06%.
Dividend Growth(5Y)-5.06%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 71.68% of the earnings are spent on dividend by MARR. This is not a sustainable payout ratio.
DP71.68%
EPS Next 2Y4.5%
EPS Next 3Y7.6%
MARR.MI Yearly Income VS Free CF VS DividendMARR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M
MARR.MI Dividend Payout.MARR.MI Dividend Payout, showing the Payout Ratio.MARR.MI Dividend Payout.PayoutRetained Earnings

MARR SPA

BIT:MARR (2/12/2026, 11:59:57 AM)

9.36

-0.04 (-0.43%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)01-13
Earnings (Next)05-13
Inst Owners24.35%
Inst Owner ChangeN/A
Ins Owners50.42%
Ins Owner ChangeN/A
Market Cap622.72M
Revenue(TTM)3.05B
Net Income(TTM)53.74M
Analysts76.67
Price Target11.88 (26.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.49%
Yearly Dividend0.6
Dividend Growth(5Y)-5.06%
DP71.68%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-11.28%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 11.28
Fwd PE 13.13
P/S 0.2
P/FCF 33.28
P/OCF 11.63
P/B 1.97
P/tB 4.27
EV/EBITDA 7.87
EPS(TTM)0.83
EY8.87%
EPS(NY)0.71
Fwd EY7.61%
FCF(TTM)0.28
FCFY3%
OCF(TTM)0.8
OCFY8.6%
SpS45.79
BVpS4.74
TBVpS2.19
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.41
Profitability
Industry RankSector Rank
ROA 3.98%
ROE 17.04%
ROCE 13.54%
ROIC 9.46%
ROICexc 13.6%
ROICexgc 20.95%
OM 3.09%
PM (TTM) 1.76%
GM 7.74%
FCFM 0.61%
ROA(3y)3.25%
ROA(5y)2.51%
ROE(3y)11.13%
ROE(5y)8.54%
ROIC(3y)6.59%
ROIC(5y)5.15%
ROICexc(3y)9.5%
ROICexc(5y)7.64%
ROICexgc(3y)14.76%
ROICexgc(5y)12.13%
ROCE(3y)9.43%
ROCE(5y)7.37%
ROICexgc growth 3Y-2.5%
ROICexgc growth 5Y-13.81%
ROICexc growth 3Y0.65%
ROICexc growth 5Y-11.99%
OM growth 3Y-4.69%
OM growth 5Y-10.77%
PM growth 3Y-5.22%
PM growth 5Y-12.22%
GM growth 3Y2.34%
GM growth 5Y1.72%
F-Score3
Asset Turnover2.26
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 27.61
Debt/EBITDA 3.03
Cap/Depr 144.76%
Cap/Sales 1.14%
Interest Coverage 250
Cash Conversion 45.32%
Profit Quality 34.81%
Current Ratio 1.44
Quick Ratio 1.02
Altman-Z 3.37
F-Score3
WACC6.27%
ROIC/WACC1.51
Cap/Depr(3y)107.37%
Cap/Depr(5y)94.25%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.35%
EPS 3Y7.67%
EPS 5Y-8.05%
EPS Q2Q%-27.17%
EPS Next Y-10.47%
EPS Next 2Y4.5%
EPS Next 3Y7.6%
EPS Next 5YN/A
Revenue 1Y (TTM)0.56%
Revenue growth 3Y12.68%
Revenue growth 5Y4.24%
Sales Q2Q%0.97%
Revenue Next Year2.63%
Revenue Next 2Y2.85%
Revenue Next 3Y3.18%
Revenue Next 5Y3.62%
EBIT growth 1Y-23.54%
EBIT growth 3Y7.4%
EBIT growth 5Y-6.98%
EBIT Next Year40.61%
EBIT Next 3Y20.45%
EBIT Next 5YN/A
FCF growth 1Y27.25%
FCF growth 3Y-31.25%
FCF growth 5Y-12.02%
OCF growth 1Y41.34%
OCF growth 3Y-19.18%
OCF growth 5Y-3.88%

MARR SPA / MARR.MI FAQ

What is the ChartMill fundamental rating of MARR SPA (MARR.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to MARR.MI.


What is the valuation status of MARR SPA (MARR.MI) stock?

ChartMill assigns a valuation rating of 5 / 10 to MARR SPA (MARR.MI). This can be considered as Fairly Valued.


How profitable is MARR SPA (MARR.MI) stock?

MARR SPA (MARR.MI) has a profitability rating of 4 / 10.


What is the earnings growth outlook for MARR SPA?

The Earnings per Share (EPS) of MARR SPA (MARR.MI) is expected to decline by -10.47% in the next year.


Can you provide the dividend sustainability for MARR stock?

The dividend rating of MARR SPA (MARR.MI) is 6 / 10 and the dividend payout ratio is 71.68%.